Bright Capital leads Series A round for FloDesign Sonics

FloDesign Sonics has received $10 million in Series A funding. Bright Capital led the round with participation from investors that included Ventry Industries. Based in Wilbraham, Mass., FloDesign Sonics is a provider of acoustic separation technology.

Siluria Technologies Appoints to Board

Siluria Technologies has appointed Karl Kurz to the company’s board of directors. Siluria is a company that converts natural gas into chemicals and fuels. It is backed by ARCH Venture Partners, The Wellcome Trust, Alloy Ventures, Kleiner Perkins Caufield & Byers, Bright Capital, Altitude Life Science Ventures, Lux Capital and Vulcan Capital.

BASF Venture Capital Puts $5M into Solida

BASF Venture Capital has put $5 million into Solidia Technologies, a maker of building and construction materials, as part of a $27 million financing round. The round also includes participation from Kleiner Perkins Caufield and Byers, BP Ventures and Bright Capital, the venture arm of RU-COM Corp. PRESS RELEASE BASF Venture Capital GmbH is investing […]

BASF Venture Capital Backs Solidia Technologies

BASF Venture Capital is investing $5 million in Solidia Technologies as part of a $27 million financing round. The current round of financing also includes Kleiner Perkins Caufield and Byers, BP Ventures and Bright Capital, the venture arm of RU-COM Corporation. The company is headquartered in Piscataway (New Jersey) and has 28 employees. PRESS RELEASE […]

SuVolta Attracts Further Funding

SuVolta, a developer of PowerShrink(TM) low-power IC technology that cuts chip power consumption by 50 to 90 percent, has secured $17.6 million in venture funding. New investor Bright Capital participated in the round, joining existing SuVolta investors including Kleiner Perkins Caufield & Byers (KPCB), August Capital, New Enterprise Associates (NEA), Northgate Capital, DAG Ventures and […]

CardioDx Seals $60M in Equity Financing

CardioDx, a company developing cardiovascular genomic diagnostics, has raised $60 million in new equity funding. New investors Longitude Capital, J.P. Morgan, Acadia Woods Partners, Artiman Ventures, and Bright Capital, the venture arm of RU-COM, participated in the round, which also included the company’s previous investors. The company has raised money previously from Kleiner, Perkins, Caufield & Byers, Mohr Davidow Ventures, TPG Biotech, Intel Capital, Pappas Ventures, DAG Ventures, Asset Management Group and GE Capital. Funding will be used to expand reimbursement coverage in the United States for the company’s blood-based gene expression test for obstructive coronary artery disease, as well as to continue development of future products. The company, based in Palo Alto, Calif., closed a $45 million round in May 2010.

PEHUB Community

Join the 12493 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

Look Who’s Tweeting

Reuters VC and PE feed

RSS Feed Widget

Groups